These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 36002258)

  • 1. Identifying inhibitors of NSP16-NSP10 of SARS-CoV-2 from large databases.
    Nguyen HL; Thai NQ; Li MS
    J Biomol Struct Dyn; 2023; 41(15):7045-7054. PubMed ID: 36002258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of naphthyridine and quinoline derivatives as potential Nsp16-Nsp10 inhibitors: a pharmacoinformatics study.
    Aldahham BJM; Al-Khafaji K; Saleh MY; Abdelhakem AM; Alanazi AM; Islam MA
    J Biomol Struct Dyn; 2022 Jun; 40(9):3899-3906. PubMed ID: 33252031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational Investigation of Structural Dynamics of SARS-CoV-2 Methyltransferase-Stimulatory Factor Heterodimer nsp16/nsp10 Bound to the Cofactor SAM.
    Sk MF; Jonniya NA; Roy R; Poddar S; Kar P
    Front Mol Biosci; 2020; 7():590165. PubMed ID: 33330626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and functional insights into the 2'-O-methyltransferase of SARS-CoV-2.
    Deng J; Gong F; Li Y; Tan X; Liu X; Yang S; Chen X; Wang H; Liu Q; Shen C; Zhou L; Chen Y
    Virol Sin; 2024 Aug; 39(4):619-631. PubMed ID: 38969340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virtual screening, ADME/T, and binding free energy analysis of anti-viral, anti-protease, and anti-infectious compounds against NSP10/NSP16 methyltransferase and main protease of SARS CoV-2.
    Maurya SK; Maurya AK; Mishra N; Siddique HR
    J Recept Signal Transduct Res; 2020 Dec; 40(6):605-612. PubMed ID: 32476594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Interactions of Zyesami with the SARS-CoV-2 nsp10/nsp16 Protein Complex.
    Alnomasy SF; Alotaibi BS; Aldosari ZM; Mujamammi AH; Alzamami A; Anand P; Akhter Y; Khan FR; Hasan MR
    Comb Chem High Throughput Screen; 2023; 26(6):1196-1203. PubMed ID: 35975856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Simulation-Based Investigation of Highly Potent Natural Products to Abrogate Formation of the nsp10-nsp16 Complex of SARS-CoV-2.
    Mohammad A; Alshawaf E; Marafie SK; Abu-Farha M; Al-Mulla F; Abubaker J
    Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33919870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of the Methyl Donor
    Aouadi W; Blanjoie A; Vasseur JJ; Debart F; Canard B; Decroly E
    J Virol; 2017 Mar; 91(5):. PubMed ID: 28031370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronavirus nsp10/nsp16 Methyltransferase Can Be Targeted by nsp10-Derived Peptide In Vitro and In Vivo To Reduce Replication and Pathogenesis.
    Wang Y; Sun Y; Wu A; Xu S; Pan R; Zeng C; Jin X; Ge X; Shi Z; Ahola T; Chen Y; Guo D
    J Virol; 2015 Aug; 89(16):8416-27. PubMed ID: 26041293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide inhibitors against SARS-CoV-2 2'-O-methyltransferase involved in RNA capping: A computational approach.
    Dutta M; Iype E
    Biochem Biophys Rep; 2021 Sep; 27():101069. PubMed ID: 34250275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A High-Throughput Radioactivity-Based Assay for Screening SARS-CoV-2 nsp10-nsp16 Complex.
    Khalili Yazdi A; Li F; Devkota K; Perveen S; Ghiabi P; Hajian T; Bolotokova A; Vedadi M
    SLAS Discov; 2021 Jul; 26(6):757-765. PubMed ID: 33874769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virtual screening and molecular dynamics simulation for identification of natural antiviral agents targeting SARS-CoV-2 NSP10.
    Zhao H; Liu J; He L; Zhang L; Yu R; Kang C
    Biochem Biophys Res Commun; 2022 Oct; 626():114-120. PubMed ID: 35988295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated molecular and quantum mechanical approach to identify novel potent natural bioactive compound against 2'-O-methyltransferase (nsp16) of SARS-CoV-2.
    Thomas J; Kumar S; Satija J
    J Biomol Struct Dyn; 2024; 42(4):1999-2012. PubMed ID: 37129206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of SARS-CoV-2 nsp10-nsp16 in complex with small molecule inhibitors, SS148 and WZ16.
    Klima M; Khalili Yazdi A; Li F; Chau I; Hajian T; Bolotokova A; Kaniskan HÜ; Han Y; Wang K; Li D; Luo M; Jin J; Boura E; Vedadi M
    Protein Sci; 2022 Sep; 31(9):e4395. PubMed ID: 36040262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging variants of SARS-CoV-2 NSP10 highlight strong functional conservation of its binding to two non-structural proteins, NSP14 and NSP16.
    Wang H; Rizvi SRA; Dong D; Lou J; Wang Q; Sopipong W; Su Y; Najar F; Agarwal PK; Kozielski F; Haider S
    Elife; 2023 Dec; 12():. PubMed ID: 38127066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel mutations in the methyltransferase complex (Nsp10-Nsp16) of SARS-CoV-2.
    Azad GK
    Biochem Biophys Rep; 2020 Dec; 24():100833. PubMed ID: 33072893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virtual screening of molecular databases for potential inhibitors of the NSP16/NSP10 methyltransferase from SARS-CoV-2.
    Gomes JPA; Rocha LO; Leal CEY; Filho EBA
    J Mol Struct; 2022 Aug; 1261():132951. PubMed ID: 35369609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico investigation of potential small molecule inhibitors of the SARS-CoV-2 nsp10-nsp16 methyltransferase complex.
    Liang J; Pitsillou E; Burbury L; Hung A; Karagiannis TC
    Chem Phys Lett; 2021 Jul; 774():138618. PubMed ID: 33850334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular dynamic simulations reveal anti-SARS-CoV-2 activity of mitocurcumin by potentially blocking innate immune evasion proteins NSP3 and NSP16.
    Pal D; Checker R; Kutala VK; Sandur SK
    Mol Divers; 2023 Apr; 27(2):635-649. PubMed ID: 35538380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational investigation of potent inhibitors against SARS-CoV-2 2'-O-methyltransferase (nsp16): Structure-based pharmacophore modeling, molecular docking, molecular dynamics simulations and binding free energy calculations.
    Shi L; Wen Z; Song Y; Wang J; Yu D
    J Mol Graph Model; 2022 Dec; 117():108306. PubMed ID: 36063745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.